- Home
- News and Resources
- Resources
- Survivial Effects of ZDV, ddi, and ddC in Patients With CD4
Survivial Effects of ZDV, ddi, and ddC in Patients With CD4
Seven major clinical trials for the treatment of HIV-infected individuals are investigated. The treatments used in these trials were zidovudine, dideoxyinosine, dideoxycytosine, and one combination for patient with CD4 cell counts <500 cells/mm.